Yam tshuaj twg yog Cabozantinib-S-Malate

Jun 26, 2026 Tso lus

Koj puas tau xav tias yuav ua li cas cov tshuaj zoo li Cabozantinib-S-malate- muaj peev xwm ua tau raws li lub hom phiaj thiab cuam tshuam cov kab mob ntawm tes taw qhia txoj hauv kev- tiag tiag " tswj" cell lub neej thiab kev tuag nyob rau hauv ib qho chaw molecular microenvironment complex? Cia peb kawm ua ke.

 

Yam tshuaj twg yog Cabozantinib-S-malate

Cabozantinib-S-malate APIyog cov khoom siv tshuaj nquag (API) daim ntawv ntawm Cabozantinib, uas twb muaj lawm tshwj xeeb raws li S-malate ntsev. Nws sawv raws li kev tshawb fawb tseem ceeb hauv thaj tsam ntawm ntau lub hom phiaj tyrosine kinase inhibitors. Cov tshuaj no ua raws li ntau yam xov tooj ntawm tes taw qhia txoj hauv kev-xws li MET, VEGFR2, RET, thiab AXL- uas cuam tshuam zoo rau hauv cov txheej txheem physiological xws li kev txawv txav ntawm cov cellular proliferation, pathological angiogenesis, thiab metastasis ntawm cov ntaub so ntswg. Yog li ntawd, nws tau txais kev saib xyuas tseem ceeb hauv thaj chaw ntawm biopharmaceuticals niaj hnub thiab kev tshawb fawb molecular mechanism. Piv nrog rau nws daim ntawv pub dawb- hauv paus, S-malate ntsev txhim kho qhov sib xyaw kom ruaj khov, solubility, thiab bioavailability, yog li muab cov txiaj ntsig sib txawv rau kev txhim kho ntawm cov ntawv siv hauv qhov ncauj, kev xa tshuaj, thiab loj- nplai kev lag luam.

What class of drug is Cabozantinib-S-malate

Tsis tas li ntawd, daim ntawv ntsev no txhim kho API qhov chaw ruaj khov thiab kev sib xyaw ua ke, ua rau nws cov ntawv thov dav hauv kev tsim kho tshuaj thiab kev tshawb fawb txog kev tshawb fawb. Raws li cov khoom xyaw tseem ceeb, Cabozantinib-S-malate feem ntau yog siv rau hauv kev txhim kho tom qab ntawm cov ntawv ua tiav, xws li ntsiav tshuaj thiab tshuaj ntsiav, thiab tseem yog ib qho tseem ceeb ntawm kev tsom mus rau kev tshawb fawb tam sim no ntawm cov phiaj xwm teeb tsa thiab kev tswj hwm ntawm tes. Nrog rau kev nce qib ntawm cov tshuaj precision thiab molecular biology technologies, cov multitargeted tebchaw no qhia tau hais tias muaj peev xwm ntau dua rau kev siv hauv kev tswj cov kev ua ntawm tes, kawm cov ntaub so ntswg microenvironments thiab tsim tshiab biopharmaceuticals. Yog tias koj txaus siab rau Cabozantinib-S-malate API, thov hu rau Xi'an Sonwu txhua lub sijhawm.

 

Dab tsi yog qhov kev ua ntawm Cabozantinib -S- malate

Cabozantinib-S-malate yog multitargeted tyrosine kinase inhibitor (TKI), txhais tau hais tias nws thaiv kev ua haujlwm ntawm ntau yam enzymes-tshwj xeeb yog tyrosine kinases- uas tswj cov txheej txheem tseem ceeb ntawm cov cellular physiological xws li kev loj hlob ntawm tes, kev ciaj sia, thiab kev hloov pauv. Nws mechanism ntawm qhov kev txiav txim tuaj yeem sau tau raws li hauv qab no:
1. Inhibition of Receptor Tyrosine Kinases (RTKs)
Nws tsom mus rau ntau yam RTKs, suav nrog MET (Hepatocyte Growth Factor Receptor), uas koom nrog cov txheej txheem ntawm kev loj hlob ntawm tes tsis zoo, kev tsiv teb tsaws, thiab cov ntaub so ntswg ntxeem tau. VEGFR2 (Vascular Endothelial Growth Factor Receptor 2): Ib qho tseem ceeb ntawm kev tsim cov hlab ntsha hauv cov ntaub so ntswg. AXL: Txhawb kev ciaj sia thiab ntxeem tau ntawm cov hlwb txawv txav, nrog rau kev txhim kho ntawm kev tiv thaiv kev kho. RET: Ua lub luag haujlwm hauv qee yam kab mob uas tau tsav los ntawm caj ces. Los ntawm inhibiting cov receptors no, Cabozantinib thaiv cov kev taw qhia txoj hauv kev uas txhawb nqa cov nqaij mos loj hlob thiab txhim kho microenvironmental.
2. Kev thaiv ntawm txoj kev taw qhia hauv qab
Thaum cov kinases uas tau hais los saum no raug txwv, lawv txoj hauv kev taw qhia nqes hav -xws li RAS/MAPK, PI3K/AKT, thiab STAT3- kuj yog li ntawd. Cov kev no feem ntau yog lub luag haujlwm rau kev tswj hwm:
Cell proliferation thiab ciaj sia taus
Cell migration thiab ntxeem tau
Angiogenesis (kev tsim cov hlab ntsha tshiab)
Kev thaiv cov txheej txheem no qeeb kev loj hlob thiab kev sib kis ntawm cov hlwb txawv txav thiab txo cov kev tsim cov kab mob vascular uas txhawb nqa lawv.

What is the mechanism of action of Cabozantinib-S-malate

3. Anti-Cov teebmeem angiogenic
Los ntawm kev tsom VEGFR2 thiab MET, qhov sib xyaw ua ke txo cov vascularization ntawm cov ntaub so ntswg txawv txav, yog li txwv cov khoom noj thiab oxygen xa mus rau cov ntaub so ntswg. Cov nyhuv no tseem ceeb tshwj xeeb rau kev ua kom qeeb ntawm cov kab mob proliferative.
4. Kev cuam tshuam rau Microenvironment
Nws tsis ncaj qha cuam tshuam rau cov ntaub so ntswg microenvironment los ntawm kev txo cov teeb liab uas txhawb nqa cov ntaub so ntswg txawv txav thiab txhawb kev ciaj sia ntawm cov hlwb txawv txav.
 

Dab tsi yog cov kev mob tshwm sim ntawm Cabozantinib-S-malate

Cabozantinib-S-malate tuaj yeem ua rau muaj ntau yam kev mob tshwm sim, vim tias nws cov txheej txheem ntawm kev ua haujlwm cuam tshuam nrog kev cuam tshuam ntau lub xov tooj ntawm tes uas cuam tshuam nrog kev mob ntshav qab zib, kev loj hlob ntawm tes, thiab kho cov ntaub so ntswg. Qhov hnyav thiab zaus ntawm cov kev tsis zoo no txawv nyob ntawm qhov ntau npaum li cas, kev kho mob ntev, thiab tus neeg mob tag nrho.
Cov kev mob tshwm sim muaj xws li: qaug zog lossis qaug zog, tsis qab los noj mov, xeev siab, ntuav lossis raws plab, cem quav, poob phaus, hloov kev xav, qhov ncauj qhov ntswg lossis qhov ncauj khaus, ntshav siab, tes-ko taw syndrome (tshwj xeeb los ntawm liab, o, mob, lossis tev ntawm xib teg thiab cov plaub hau hloov xim), ho plab tsis xis nyob, thiab nce siab siab enzyme qib raws li qhia los ntawm kev sim kuaj.

What are the common side effects of Cabozantinib-S-malate

Qee tus neeg mob kuj yuav ntsib cov tawv nqaij - cuam tshuam txog kev phiv, xws li tawv nqaij qhuav, ua pob liab liab, lossis ua rau tawv nqaij rhiab heev. Vim hais tias cov tshuaj cuam tshuam rau vascular signaling, tej zaum nws yuav ua rau qeeb qhov txhab kho los yog ua rau los ntshav - cuam tshuam.
Qhov hnyav dua, txawm tias tsis tshua muaj tshwm sim, qhov tshwm sim tsis zoo yuav suav nrog: kub siab hnyav, cov xwm txheej thromboembolic, thiab nce qib ntawm cov protein hauv cov zis. Yog li, muab lub peev xwm rau cov tshuaj no ua rau muaj kev phiv tsis zoo, cov tshuaj uas muaj cov tshuaj no feem ntau xav tau kev tswj hwm hauv kev saib xyuas kev kho mob nruj, nrog rau kev saib xyuas cov ntshav siab, lub siab ua haujlwm, lub raum ua haujlwm, thiab lub cev tag nrho.

 

Yog tias koj xav nug txog tus nqi ntawm Cabozantinib-S-malate API lossis lwm yam ntaub ntawv khoom, thov hu rau Xi'an Sonwu ncaj qha.
Email:sales@sonwu.com
Siv tau: https://amitcellulose.com/croscarmellose-sodium/

Xa kev nug

whatsapp

teams

Tug

Kev nug